Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5207279
Max Phase: Preclinical
Molecular Formula: C33H42N8O4S
Molecular Weight: 646.82
Associated Items:
ID: ALA5207279
Max Phase: Preclinical
Molecular Formula: C33H42N8O4S
Molecular Weight: 646.82
Associated Items:
Canonical SMILES: CC(C)(C)NC(=O)NC1CCN(C(=O)[C@H](Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2cccc(-c3ccc(C(=N)N)cc3)c2)CC1
Standard InChI: InChI=1S/C33H42N8O4S/c1-33(2,3)39-32(43)38-26-14-16-41(17-15-26)31(42)28(19-21-6-4-8-25(18-21)30(36)37)40-46(44,45)27-9-5-7-24(20-27)22-10-12-23(13-11-22)29(34)35/h4-13,18,20,26,28,40H,14-17,19H2,1-3H3,(H3,34,35)(H3,36,37)(H2,38,39,43)/t28-/m0/s1
Standard InChI Key: PZUMYGZUFLLTBN-NDEPHWFRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 646.82 | Molecular Weight (Monoisotopic): 646.3050 | AlogP: 2.90 | #Rotatable Bonds: 10 |
Polar Surface Area: 207.35 | Molecular Species: BASE | HBA: 6 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.01 | CX Basic pKa: 11.76 | CX LogP: 1.03 | CX LogD: -3.08 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.13 | Np Likeness Score: -1.10 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):